COMMUNIQUÉS West-GlobeNewswire

INSIGHT: First Patient Dosed in the 4th arm called “INSIGHT-004”
06/06/2019
Highlights First patient received first dose in INSIGHT-004, a phase I clinical trial Evaluates the combination of eftilagimod alpha with avelumab (BAVENCIO®) in different cancer indications Patient recruitment for the [...]
Three-Year Clinical Trial Results Support ILUVIEN® Launch in Europe for the Prevention of Relapse in Recurrent Non-Infectious Uveitis Affecting the Posterior Segment
06/06/2019
A single ILUVIEN implant significantly delayed recurrence and reduced uveitis symptoms upon recurrence compared to active control arm Recently approved in Europe, ILUVIEN is expected to launch in certain EU countries [...]
ContraVir Pharmaceuticals Sets the Stage for CRV431 Development in NASH with Positive Results from Second Model of Liver Fibrosis
06/06/2019
- Further evidence of unique mechanism beneficial to NASH treatment - EDISON, N.J., June 06, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development [...]
Tabula Rasa HealthCare’s DoseMe Signs 3-Year Agreement with Portugal’s National Health Service
06/06/2019
Recognizes the importance of individualizing medication therapy for every patient MOORESTOWN, N.J., June 06, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ: TRHC), precision dosing software [...]
PSIQ to Exhibit at ASD Market Week, the Most Comprehensive B2B Trade Show for Consumer Merchandise in the United States July 28th Through July 31st, 2019
06/06/2019
SUNRISE, Fla., June 06, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ ) through its subsidiary Elite Products International, Inc. (“Elite”) announces it will be attending ASD Market Week, the most [...]
BioSig Allowed a U.S. Patent for PURE EP™ Simulator
06/06/2019
Santa Monica, CA, June 06, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
RTI Surgical® Reaches 5,000 Implant Milestone for Fortilink® Interbody Fusion Systems with TETRAfuse® 3D Technology
06/06/2019
Demonstrates Rapid Growth of Family of Devices Designed to Participate in Fusion Without Compromising Mechanical Integrity or Radiographic Visibility DEERFIELD, Ill., June 06, 2019 (GLOBE NEWSWIRE) -- RTI Surgical [...]
Progenics Pharmaceuticals Announces Presentations at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2019 Annual Meeting
06/06/2019
NEW YORK, June 06, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative targeted medicines and artificial intelligence to find, fight and follow cancer, today [...]
Axovant Announces 6-Month Follow-Up Data From First Cohort of SUNRISE-PD Phase 2 Trial of AXO-Lenti-PD and Pipeline Update
06/06/2019
AXO-Lenti-PD was observed to be generally well tolerated at six months, and continued to demonstrate benefits in both patients across multiple measures after a single administration Totality of data across the program [...]
New Studies Highlight Potential for T2Bacteria and T2Candida Panels to Improve Outcomes and be Cost-Effective for Sepsis Patients in the Medical Intensive Care Unit and Emergency Department
06/06/2019
LEXINGTON, Mass., June 06, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today the [...]
Enlivex Therapeutics Provides Clinical Update on Positive Safety Profile of Its Off-The-Shelf Cell Therapy Product in First Three Severe Sepsis Patients
06/06/2019
Nes Ziona, Israel, June 06, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today provided a clinical update on the positive safety profile of its off-the-shelf [...]
Protalix BioTherapeutics and Chiesi Farmaceutici S.p.A to Apply for Accelerated Approval of pegunigalsidase alfa for the Treatment of Fabry Disease in the United States
06/06/2019
BLA Submission Expected First Quarter 2020 CARMIEL, Israel, June 06, 2019 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), or Protalix, and Chiesi Farmaceutici S.p.A, an international [...]
ContraFect Awarded $7.2 Million USAMRDC Grant to Support the Advancement of Lysin Candidate CF-296
06/06/2019
YONKERS, N.Y., June 06, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of biologic therapies for life-threatening, drug- [...]
Athenex Provides an Update on its Chongqing API Plant
06/06/2019
BUFFALO, N.Y., June 06, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Anavex Life Sciences Announces First Patient Dosed in Phase 2 Clinical Trial of ANAVEX®2-73 for the Treatment of Rett Syndrome (AVATAR)
06/06/2019
Study will incorporate genomic precision medicine ANAVEX®2-73-specific biomarkers NEW YORK, June 06, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage [...]
Seelos Therapeutics Provides Update on Pipeline Developments and Corporate Highlights
06/06/2019
─ Scheduled to Meet with FDA to Design Proof-of-Concept Study in Suicidality-PTSD ─ Appoints Warren W. Wasiewski, MD as Chief Scientific Officer ─ Seelos to Webcast Presentation at the Jefferies 2019 Healthcare [...]
Arvinas to Present at the Goldman Sachs 40th Annual Global Healthcare Conference
06/06/2019
NEW HAVEN, Conn., June 06, 2019 (GLOBE NEWSWIRE) -- Arvinas Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on protein degradation, today announced that Ian Taylor, Ph.D., Chief [...]
Athenex and PharmaEssentia Announce Positive Early Signals of Clinical Activity of KX2-391 (INN: tirbanibulin) in Patients with Psoriasis
06/06/2019
BUFFALO, N.Y. and TAIPEI, Taiwan, June 06, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for [...]
Bavarian Nordic A/S - Articles of Association
06/06/2019
Updated Articles of Association for Bavarian Nordic A/S Attachment Bavarian Nordic - Articles of Association

Pages